MAP4K4

MAP4K4
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesMAP4K4, FLH21957, HEL-S-31, HGK, MEKKK4, NIK, mitogen-activated protein kinase kinase kinase kinase 4
External IDsOMIM: 604666; MGI: 1349394; HomoloGene: 7442; GeneCards: MAP4K4; OMA:MAP4K4 - orthologs
Orthologs
SpeciesHumanMouse
Entrez

9448

26921

Ensembl

ENSG00000071054

ENSMUSG00000026074

UniProt

O95819

P97820

RefSeq (mRNA)

NM_001242559
NM_001242560
NM_004834
NM_145686
NM_145687

NM_001252200
NM_001252201
NM_001252202
NM_008696

RefSeq (protein)

NP_001229488
NP_001229489
NP_004825
NP_663719
NP_663720

NP_001239129
NP_001239130
NP_001239131
NP_032722

Location (UCSC)Chr 2: 101.7 – 101.89 MbChr 1: 39.9 – 40.03 Mb
PubMed search
Wikidata
View/Edit HumanView/Edit Mouse

Mitogen-activated protein kinase kinase kinase kinase 4 (MAP4K4) – also known as hepatocyte progenitor kinase-like/germinal center kinase-like kinase (HGK) and Nck-interacting kinase (NIK) – is an enzyme, specifically a serine/threonine (S/T) kinase encoded by the MAP4K4 gene in humans.

MAP4K4 is involved in a wide array of physiological processes including cell migration, proliferation and adhesion; its activity has been implicated in systemic inflammation, metabolic disorders, cardiovascular disease and cancer.

While MAP4K4 has been found to be upregulated in a wide array of cancers, there is currently limited information regarding its specific involvement. However, there is increasing evidence that suggests MAP4K4 has an important role in the development and progression of cancer, and may serve as a novel target for cancer therapeutics.